Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 27, 2022The Journal of Physical Chemistry Letters

Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization

View Full Paper
Ask AI
Bookmark
Share

Authors

DXDanyang XiongXZXiaoyu ZhaoSLSong Luo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xiong et al. (2022) studied this question.

synapsesocial.com/papers/6aa5b6c0affc7bfe5364b474https://doi.org/10.1021/acs.jpclett.2c00912
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-192020 · 90 citations
  2. 2Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV0162021 · 522 citations
  3. 3Allosteric Cross-Talk among Spike’s Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor2021 · 41 citations
  4. 4SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-192020 · 1,427 citations
  5. 5Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England2021 · 2,621 citations